Astrazenica is a vaccine play that is holding its golden pocket low at the .618 ratio. These setups are strong possibility for an uptrend in the future.
We're looking at a stop-loss underneath the latest low that gives a strong risk-to-reward scenario for Astrazenica moving forward. As more vaccine's are set to deploy, we think Astrazenica can capitalize.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.